PolyPid PYPD
NASDAQ PYPD
$5.19 -0.18 (-3.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

PolyPid (PYPD) Net Income towards Common Stockholders (2019 - 2026)

Updated

PolyPid's Net Income towards Common Stockholders came in at $7.84 million for Q2 2026, down 21.4% from $9.98 million a year earlier but up 1.5% from the prior quarter.

Analysis

PolyPid (PYPD) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, PolyPid reported Net Income towards Common Stockholders of $31.5 million, down 8.8% year-over-year; for FY2025, it came in at $34.17 million, up 17.7% from FY2024.

  • Net Income towards Common Stockholders carries a five-year compound annual growth rate of -0.3% (FY2020 to FY2025).
  • Going back by year, Net Income towards Common Stockholders was $29.02 million in FY2024 (+21.6%), $23.87 million in FY2023 (-39.7%), $39.56 million in FY2022 (-7.1%) and $42.6 million in FY2021 (+22.6%).
  • The five-year range for quarterly Net Income towards Common Stockholders is $5.6 million (Q3 2023) to $13.5 million (Q4 2021).
  • Year-over-year, Net Income towards Common Stockholders has declined for four consecutive quarters, with growth averaging 15.9% over the last eight quarters.
  • The fastest year-over-year change in Net Income towards Common Stockholders over five years came in Q4 2021 (growth of 78.9%), and the weakest in Q4 2022 (a decline of 51.6%).
  • Business Quant data shows PYPD's Net Income towards Common Stockholders at $7.73 million (Q1 2026), $8.47 million (Q4 2025) and $7.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.61 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -248.00 Mn
10 PolyPid 94.48 Mn 45.28 Mn - 7.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.84 Mn
Mar 31, 2026 7.73 Mn
Dec 31, 2025 8.47 Mn
Sep 30, 2025 7.45 Mn
Jun 30, 2025 9.98 Mn
Mar 31, 2025 8.27 Mn
Dec 31, 2024 8.52 Mn
Sep 30, 2024 7.76 Mn
Jun 30, 2024 6.29 Mn
Mar 31, 2024 6.45 Mn
Dec 31, 2023 6.36 Mn
Sep 30, 2023 5.60 Mn
Jun 30, 2023 5.84 Mn
Mar 31, 2023 6.07 Mn
Dec 31, 2022 6.54 Mn
Sep 30, 2022 9.27 Mn
Jun 30, 2022 11.85 Mn
Mar 31, 2022 11.87 Mn
Dec 31, 2021 13.50 Mn
Sep 30, 2021 9.94 Mn
API Access

PolyPid Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=PYPD&period=max&api_key=YOUR_API_KEY